News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
154 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (14534)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
BioMidwest
Toshiba Medical Introduces New CT System that Ensures Healthcare Providers Don’t Have to Choose Between High-Quality CT Images and Patient Safety
The new Aquilion Prime SP can generate 160 unique slices per rotation with 0.35-second scanning, reducing time required to diagnosis.
November 27, 2017
·
2 min read
BioMidwest
Toshiba Medical Enhances Multipurpose System to Simplify Exams and Prioritize Safety
Toshiba Medical’s Ultimax-i FPD multipurpose system maximizes clinical versatility by providing orthopedic, G.I., pain management, urology, routine radiography and angiography lab capabilities within a single R&F room.
November 27, 2017
·
3 min read
BioMidwest
Toshiba Medical’s Aplio i-series Platform Delivers New Clinical Applications and Transducers to Help Clinicians Provide Quick, Efficient Diagnoses
The Aplio i-series platform includes iPerformance technologies that deliver extreme processing power and help health care providers give reliable, quick diagnoses.
November 27, 2017
·
4 min read
Deals
PE Firm Altus Capital Partners Pays $50M for MGC Diagnostics
Altus will acquire all outstanding shares of MGCD for $11.03 per share in cash, or approximately $503M.
November 27, 2017
·
4 min read
Policy
EMA Accepts Titan Pharma’s MAA for Probuphine
The acceptance marks the beginning of the EMA’s regulatory review process for Probuphine for substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment.
November 27, 2017
·
3 min read
Business
Aerie Pharmaceuticals Announces Appointment of Nhi Ong as Director of Analytics
Mr. Ong will be responsible for directing the information and analytics functions in support of Aerie’s commercial organization.
November 27, 2017
·
5 min read
Bio NC
BioDelivery Sciences Announces Ohio Workers Compensation Adding BELBUCA and BUNAVAIL to Formulary
BUNAVAIL will be added to the formulary and covered in claims with an allowed condition for opioid use disorder, while Suboxone film, Suboxone tablet and generic equivalents, and Subutex tablet and its generic equivalents will be removed from the formulary.
November 27, 2017
·
21 min read
Drug Development
Can-Fite Enrolls First Patient in Phase II NAFLD/NASH Study With Namodenoson
There is currently no U.S. FDA approved drug for the treatment of NASH, which is an addressable pharmaceutical market estimated to reach $35-40 billion by 2025.
November 27, 2017
·
7 min read
Business
Quanterix Corporation Announces Launch of Initial Public Offering
The current expected initial public offering price is between $14.00 and $16.00 per share.
November 27, 2017
·
4 min read
Biotech Beach
Thermo Fisher Scientific’s Expanded Genome Editing Tool Kit Supports Every Step in Researchers’ Workflow
The product suite meets the full spectrum of researchers’ genome editing needs - from basic solutions for CRISPR beginners to sophisticated tools for highly efficient and precise genome editing in even the most challenging cell types.
November 27, 2017
·
4 min read
Previous
4 of 16
Next